acetylcysteine and Takotsubo Cardiomyopathy

acetylcysteine has been researched along with Takotsubo Cardiomyopathy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Horowitz, J; Mahadavan, G; Nguyen, TH; Ong, GJ; Stansborough, J; Surikow, S; Worthley, M1
Madias, JE1

Trials

1 trial(s) available for acetylcysteine and Takotsubo Cardiomyopathy

ArticleYear
The N-AcetylCysteine and RAMipril in Takotsubo Syndrome Trial (NACRAM): Rationale and design of a randomised controlled trial of sequential N-Acetylcysteine and ramipril for the management of Takotsubo Syndrome.
    Contemporary clinical trials, 2020, Volume: 90

    Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Carrier Proteins; Double-Blind Method; Free Radical Scavengers; Humans; Inflammasomes; Prospective Studies; Quality of Life; Ramipril; Takotsubo Cardiomyopathy

2020

Other Studies

1 other study(ies) available for acetylcysteine and Takotsubo Cardiomyopathy

ArticleYear
Conceivable utility of the electrocardiogram in the N-acetylcysteine and RAMipril in takotsubo syndrome trial (NACRAM).
    Contemporary clinical trials, 2020, Volume: 88

    Topics: Acetylcysteine; Electrocardiography; Humans; Ramipril; Takotsubo Cardiomyopathy

2020